Skip to Content


In the US, Trexall (methotrexate systemic) is a member of the following drug classes: antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants and is used to treat Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Breast Cancer, Choriocarcinoma, Dermatomyositis, Graft-versus-host disease, Head and Neck Cancer, Lymphoma, Meningeal Leukemia, Mycosis Fungoides, Neoplastic Diseases, Non-Hodgkin's Lymphoma, Non-Small Cell Lung Cancer, Osteosarcoma, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Solid Tumors, Systemic Sclerosis and Trophoblastic Disease.

US matches:

Ingredient matches for Trexall


Methotrexate is reported as an ingredient of Trexall in the following countries:

  • United States

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.